Loading quotes...
Forecast
| Buy |
1 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
Dominari Holdings changes terms for Series A warrants and offers reduced exercise price
Dominari Holdings agreed incentive arrangements with holders of Series A warrants and is offering two options: exercise all warrants by September 11, 2026 at a reduced price of $2.20 per share, or exchange unexercised warrants for common shares at a ratio of 1 share for every 5 underlying warrants. If holders choose option A, the company expects gross proceeds of about $2.9 million; under option B approximately 115,000 exchange shares would be issued. After the transactions, about 1.2 million Series A warrants would likely remain outstanding; the potential shares are registered for resale in an effective registration statement, while exchange shares are subject to an exemption. » More on de.investing.com
Dominari Holdings: stock rose by around 400% in 2025, strong capital-markets activity
Dominari Holdings recorded a price gain of about 400% in 2025 (from roughly $1.00 to almost $5.00) and is currently trading at approximately $4.19. The company paid dividends of around $22.2 million in 2025, generated revenue of $99.59 million (+691% YoY) and shows a very low P/E ratio of 0.46 and a price‑to‑book of 0.32. Dominari Securities completed numerous transactions, raised nearly $2 billion in capital (including leading roles in issuances) and strengthened liquidity with a current ratio of 4.74, indicating robust financial metrics and further upside potential. » More on de.investing.com
Dominari Holdings announces $10 million special dividend
Dominari Holdings will pay a cash special dividend of about $10 million (approximately $0.44 per share), payable around January 23, 2026 to shareholders of record at the close of trading on December 31, 2025. The micro‑cap company, with a market capitalization of roughly $67 million, is unusually issuing a special dividend for the first time despite the stock’s strong rise in 2025. Dominari reports a solid liquidity position (current ratio 4.74) and held about $176.2 million in cash and marketable securities as of September 30, 2025; a previously filed $2 billion shelf registration was withdrawn. Tim Ledwick was also appointed CFO, and the company is pursuing growth opportunities in areas such as AI and data centers. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 14.71m | 49.15% |
| Gross profit | 14.71m | 49.15% |
| Net profit | -4.36m | 130.96% |
| EBITDA | -2.05m | 87.45% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €37.37m |
Number of shares | 24.24m |
52-week high/low | €5.48 - €1.53 |
Dividend yield | 65.36% |
Dividends TTM | €1.01 |
Beta | 0.88 |
P/E ratio | -0.49 |
PEG ratio | 0.00 |
P/B ratio | 1.80 |
P/S ratio | 0.31 |
Company profile
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.
| Name | Dominari Holdings |
| CEO | Anthony C. Hayes |
| Headquarters | New York City,
ny USA |
| Website | |
| Sector | Financials |
| Industry | Financial Services |
| IPO | 18/03/1980 |
| Employees | 36 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | DOMH |
Frankfurt | BP2A.F |
Düsseldorf | BP2A.DU |